We are live on ! Find out more
LCS

Levin Capital Strategies Portfolio holdings

AUM $1.49B
1-Year Est. Return 30.44%
This Fund
S&P 500
This Quarter Est. Return
+5.69%
1 Year Est. Return
+30.44%
3 Year Est. Return
+88.59%
5 Year Est. Return
+121.06%
10 Year Est. Return
+327.09%
AUM
$5.82B
AUM Growth
-$977M
Cap. Flow
-$270M
Cap. Flow %
-4.64%
Top 10 Hldgs %
38.85%
Holding
370
New
37
Increased
64
Reduced
141
Closed
67

Sector Composition

Rank Sector Weight
1 Financials 22.68%
2 Technology 15.88%
3 Healthcare 14.26%
4 Consumer Staples 9.97%
5 Energy 9.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CYHHZ
351
DELISTED
Community Health Systems, Inc. Series A Contingent Value Rights
CYHHZ
$0 ﹤0.01%
25,057
EACQW
352
DELISTED
Easterly Acquisition Corp.
EACQW
-26,476
Closed -$16K
JPM.WS
353
DELISTED
JPMorgan Chase
JPM.WS
-20,062
Closed -$494K
EVHC
354
DELISTED
Envision Healthcare Holdings Inc
EVHC
-10,855
Closed -$724K
CNXR
355
DELISTED
Connecture, Inc.
CNXR
-55,570
Closed -$104K
CAB
356
DELISTED
Cabela's Inc
CAB
-45,816
Closed -$2.52M
JOY
357
DELISTED
Joy Global Inc
JOY
-228,475
Closed -$6.34M
IOC
358
DELISTED
Interoil Corporation
IOC
-31,759
Closed -$1.62M
TMH
359
DELISTED
Team Health Holdings Inc
TMH
-13,000
Closed -$423K
QLTI
360
DELISTED
QLT Inc
QLTI
-1,226,728
Closed -$2.53M
N
361
DELISTED
Netsuite Inc
N
-12,797
Closed -$1.42M
GRSHW
362
DELISTED
Gores Holdings, Inc. Warrants
GRSHW
-134,420
Closed -$161K
TBRA
363
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
-7,227
Closed -$287K
SGI
364
DELISTED
Silicon Graphics Intl.
SGI
-15,000
Closed -$115K
ZINC
365
DELISTED
HORSEHEAD HLDG CORP COM STK (DE)
ZINC
-136,071
Closed -$3K
CQH
366
DELISTED
Cheniere Energy Partners LP Holdings LLC
CQH
-20,000
Closed -$455K
LNKD
367
DELISTED
LinkedIn Corporation
LNKD
-112,628
Closed -$21.5M
MDVN
368
DELISTED
MEDIVATION, INC.
MDVN
-22,731
Closed -$1.85M

Similar funds

Levin Capital Strategies's Q4 2016 Portfolio in Review

As of Q4 2016, Levin Capital Strategies held 370 positions worth $5.82B, down 14% from $6.8B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Levin Capital Strategies withdrew a net $270M in Q4 2016, closing 67 positions and reducing 141 holdings. Its most notable exit was Univar Solutions Inc., an estimated $25.1M position sold in full.

By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 31% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Levin Capital Strategies opened a new position in Athene Holding Ltd. Class A Common Shares worth $68.8M.

  • Levin Capital Strategies's largest Q4 2016 buy was Athene Holding Ltd. Class A Common Shares: 1,433,996 shares worth $68.8M.
  • Levin Capital Strategies added most to Thermo Fisher Scientific in Q4 2016, an estimated $98.8M increase.
  • Levin Capital Strategies's biggest Q4 2016 reduction was Gilead Sciences, cutting an estimated $162M.
  • Levin Capital Strategies fully exited Univar Solutions Inc. in Q4 2016, selling an estimated $25.1M.
  • Levin Capital Strategies's ten largest holdings make up 39% of its $5.82B portfolio in Q4 2016.
  • Levin Capital Strategies opened 37 new positions and closed 67 in Q4 2016.
  • Levin Capital Strategies's portfolio value fell 14% quarter-over-quarter to $5.82B.

Based on Levin Capital Strategies's 13F filing for Q4 2016, filed 14 Feb 2017.